financetom
Business
financetom
/
Business
/
Nestle confirms discussions to acquire vitamin maker Bountiful
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nestle confirms discussions to acquire vitamin maker Bountiful
Apr 26, 2021 4:19 AM

Nestle is in discussions to buy nutritional supplement maker The Bountiful Company, the Swiss food giant said on Monday, confirming earlier reports it was close to a deal in the mid-single-digit billions. ”Nestlé S.A. today announced that it is in discussions to acquire all or part of The Bountiful Company,” Nestle said, following reports last week.

The maker of KitKat chocolate bars and Nescafe instant coffee declined to give further details.

Bountiful, which is majority-owned by private equity firm KKR Co & Inc, makes Nature’s Bounty vitamins, Osteo Bi-Flex joint-care supplements, and Puritan’s Pride vitamins and supplements.

Nestle, the world’s largest packaged food company, has been expanding its presence in consumer healthcare by pushing aggressively to acquire companies in areas beyond traditional food businesses.

Health is seen as a growing sector by Nestle and has been the focus of many of its recent acquisitions including buying a majority stake in Vital Proteins and buying Aimmune Therapeutics and IM HealthScience last year.

Bountiful was founded in 1971 in New York and is based on Long Island. It employs 4,500 people globally.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Longeveron Cellular Therapy Granted International Non-Proprietary Name
Longeveron Cellular Therapy Granted International Non-Proprietary Name
Feb 18, 2025
10:23 AM EST, 02/18/2025 (MT Newswires) -- Longeveron ( LGVN ) said Tuesday that the World Health Organization approved laromestrocel for the non-proprietary name of the company's Lomecel-B cellular therapy. The US Food and Drug Administration granted Lomecel-B regenerative medicine advanced therapy designation and fast track designation to treat mild Alzheimer's disease, and orphan drug designation, fast track designation, and...
-- Definity Financial Brief: BMO Says Operating EPS estimates unchanged post a
-- Definity Financial Brief: BMO Says Operating EPS estimates unchanged post a "Modest" Q4 2024 operating EPS beat on better underwriting income
Feb 18, 2025
10:22 AM EST, 02/18/2025 (MT Newswires) -- Price: 60.29, Change: -1.37, Percent Change: -2.22 ...
Apple's Launch of iPhone SE4 Not Seen Impacting Revenue Guidance, UBS Says
Apple's Launch of iPhone SE4 Not Seen Impacting Revenue Guidance, UBS Says
Feb 18, 2025
10:22 AM EST, 02/18/2025 (MT Newswires) -- Apple ( AAPL ) 's launch of the fourth generation of the iPhone SE this week has most likely been taken into account in the company's revenue guidance for the March quarter, UBS said in a Sunday note. UBS analysts said that the average selling price of the iPhone could decline mid-single digits...
After Toronto plane crash, Delta says 19 out of 21 passengers released from hospitals
After Toronto plane crash, Delta says 19 out of 21 passengers released from hospitals
Feb 18, 2025
Feb 18 (Reuters) - Delta Air Lines ( DAL ) said on Tuesday that 19 out of the 21 passengers transported to local hospitals after a Toronto plane crash a day earlier have been released, as officials continue a probe into why the regional jet flipped over upon landing. Investigators from Canada's Transportation Safety Board (TSB) are leading the probe...
Copyright 2023-2025 - www.financetom.com All Rights Reserved